Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.

Harrison CN, Griesshammer M, Miller C, Masszi T, Passamonti F, Zachee P, Durrant S, Pane F, Guglielmelli P, Verstovsek S, Jones MM, Hunter DS, Sun W, Li J, Khan M, Habr D, Kiladjian JJ.

Br J Haematol. 2018 Jul;182(2):279-284. doi: 10.1111/bjh.14764. Epub 2017 May 17. No abstract available.

PMID:
29984424
2.

Actualizing veterans education in nursing.

Sikes D, Francis-Johnson P, Jones MM, Opton L, Casida D, Allen PE.

J Prof Nurs. 2018 May - Jun;34(3):189-194. doi: 10.1016/j.profnurs.2017.07.009. Epub 2017 Jul 16.

PMID:
29929799
3.

Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration.

Jones MM, Winthrop KL, Nelson SD, Duvall SL, Patterson OV, Nechodom KE, Findley KE, Radonovich LJ Jr, Samore MH, Fennelly KP.

PLoS One. 2018 Jun 13;13(6):e0197976. doi: 10.1371/journal.pone.0197976. eCollection 2018.

4.

In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia.

Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH.

Med Care. 2018 Jul;56(7):626-633. doi: 10.1097/MLR.0000000000000916.

PMID:
29668648
5.

Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration.

Suda KJ, Livorsi DJ, Goto M, Forrest GN, Jones MM, Neuhauser MM, Hoff BM, Ince D, Carrel M, Nair R, Knobloch MJ, Goetz MB.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):196-201. doi: 10.1017/ice.2017.299. No abstract available.

PMID:
29417925
6.

Toxicity of Bifenthrin and Mixtures of Bifenthrin Plus Acephate, Imidacloprid, Thiamethoxam, or Dicrotophos to Adults of Tarnished Plant Bug (Hemiptera: Miridae).

Jones MM, Duckworth JL, Robertson J.

J Econ Entomol. 2018 Apr 2;111(2):829-835. doi: 10.1093/jee/tox341.

PMID:
29361174
7.

Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.

Miani C, Martin A, Exley J, Doble B, Wilson E, Payne R, Avery A, Meads C, Kirtley A, Jones MM, King S.

Health Technol Assess. 2017 Dec;21(78):1-128. doi: 10.3310/hta21780.

8.

Prevalence and Factors Associated With Multidrug-Resistant Gram-Negative Organisms in Patients With Spinal Cord Injury.

Evans CT, Fitzpatrick MA, Jones MM, Burns SP, Poggensee L, Ramanathan S, LaVela SL, Safdar N, Suda KJ.

Infect Control Hosp Epidemiol. 2017 Dec;38(12):1464-1471. doi: 10.1017/ice.2017.238. Epub 2017 Nov 21.

PMID:
29157323
9.

Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003-20131.

Goto M, McDanel JS, Jones MM, Livorsi DJ, Ohl ME, Beck BF, Richardson KK, Alexander B, Perencevich EN.

Emerg Infect Dis. 2017 Nov;23(11):1815-1825. doi: 10.3201/eid2311.161214.

10.
11.

The National Institute for Health Research at 10 Years: An Impact Synthesis: 100 Impact Case Studies.

Jones MM, Kamenetzky A, Manville C, Ghiga I, MacLure C, Harte E, Spisak A, Kirtley A, Grant J.

Rand Health Q. 2017 Jan 13;6(2):13. eCollection 2017 Jan.

12.

Placing Health Trajectories in Family and Historical Context: A Proposed Enrichment of the Life Course Health and Development Model.

Jones MM, Roy K.

Matern Child Health J. 2017 Oct;21(10):1853-1860. doi: 10.1007/s10995-017-2354-4.

PMID:
28828547
13.

To: Dr. Alfredo Morabia, Editor, AJPH.

Krieger N, Birn AE, Aviles L, Bailey Z, Cubbin C, Dearfield C, Jones MM, Lee R, Moore L, Munoz N, Simonds V, Waterman PD.

Am J Public Health. 2017 Sep;107(9):e10. doi: 10.2105/AJPH.2017.303976. No abstract available.

PMID:
28787201
14.

Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.

Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):937-944. doi: 10.1017/ice.2017.98. Epub 2017 Jun 21.

15.

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus.

Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore MH.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):848-856. doi: 10.1017/ice.2017.83. Epub 2017 Jun 1.

PMID:
28566096
16.

Management of Bacteriuria in Veterans Affairs Hospitals.

Spivak ES, Burk M, Zhang R, Jones MM, Neuhauser MM, Goetz MB, Cunningham FE; Management of Urinary Tract Infections Medication Use Evaluation Group ; Management of Urinary Tract Infections Medication Use Evaluation Group.

Clin Infect Dis. 2017 Sep 15;65(6):910-917. doi: 10.1093/cid/cix474.

17.

Association of Inpatient Antimicrobial Utilization Measures with Antimicrobial Stewardship Activities and Facility Characteristics of Veterans Affairs Medical Centers.

Graber CJ, Jones MM, Chou AF, Zhang Y, Goetz MB, Madaras-Kelly K, Samore MH, Glassman PA.

J Hosp Med. 2017 May;12(5):301-309. doi: 10.12788/jhm.2730.

18.

Patient participation in general practice based undergraduate teaching: a focus group study of patient perspectives.

Park SE, Allfrey C, Jones MM, Chana J, Abbott C, Faircloth S, Higgins N, Abdullah L.

Br J Gen Pract. 2017 Apr;67(657):e260-e266. doi: 10.3399/bjgp17X690233.

19.

The C-terminal region of the major outer sheath protein of Treponema denticola inhibits neutrophil chemotaxis.

Jones MM, Vanyo ST, Visser MB.

Mol Oral Microbiol. 2017 Oct;32(5):375-389. doi: 10.1111/omi.12180. Epub 2017 Apr 18.

PMID:
28296262
20.

Assessing Interprofessional education in a student-faculty collaborative practice network.

Young GJ, Cohen MJ, Blanchfield BB, Jones MM, Reidy PA, Weinstein AR.

Educ Prim Care. 2017 Jul;28(4):223-231. doi: 10.1080/14739879.2017.1298406. Epub 2017 Mar 12.

PMID:
28287025
21.

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Harrison CN, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L, Cervantes F, Jones MM, Sun K, McQuitty M, Stalbovskaya V, Gopalakrishna P, Barbui T.

Leukemia. 2017 Mar;31(3):775. doi: 10.1038/leu.2016.323. No abstract available.

PMID:
28248313
22.

Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years.

Fitzpatrick MA, Suda KJ, Safdar N, Burns SP, Jones MM, Poggensee L, Ramanathan S, Evans CT.

J Spinal Cord Med. 2018 Mar;41(2):199-207. doi: 10.1080/10790268.2017.1281373. Epub 2017 Feb 15.

PMID:
28198662
23.

Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.

Stevens VW, Nelson RE, Schwab-Daugherty EM, Khader K, Jones MM, Brown KA, Greene T, Croft LD, Neuhauser M, Glassman P, Goetz MB, Samore MH, Rubin MA.

JAMA Intern Med. 2017 Apr 1;177(4):546-553. doi: 10.1001/jamainternmed.2016.9045.

PMID:
28166328
24.

A Report of the Efforts of the Veterans Health Administration National Antimicrobial Stewardship Initiative.

Kelly AA, Jones MM, Echevarria KL, Kralovic SM, Samore MH, Goetz MB, Madaras-Kelly KJ, Simbartl LA, Morreale AP, Neuhauser MM, Roselle GA.

Infect Control Hosp Epidemiol. 2017 May;38(5):513-520. doi: 10.1017/ice.2016.328. Epub 2017 Jan 25.

25.

Leadership as a Health Research Policy Intervention: An Evaluation of the NIHR Leadership Programme (Phase 2).

Marjanovic S, Cochrane G, Manville C, Harte E, Chataway J, Jones MM.

Rand Health Q. 2016 Jan 29;5(3):1. eCollection 2016 Jan 29.

26.

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).

Mesa R, Vannucchi AM, Yacoub A, Zachee P, Garg M, Lyons R, Koschmieder S, Rinaldi C, Byrne J, Hasan Y, Passamonti F, Verstovsek S, Hunter D, Jones MM, Zhen H, Habr D, Martino B.

Br J Haematol. 2017 Jan;176(1):76-85. doi: 10.1111/bjh.14382. Epub 2016 Nov 8.

27.

Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.

Livorsi DJ, Goto M, Carrel M, Jones MM, McDanel J, Nair R, Alexander B, Beck B, Richardson KK, Perencevich EN.

Antimicrob Resist Infect Control. 2016 Oct 19;5:38. eCollection 2016.

28.

Taking an Antibiotic Time-out: Utilization and Usability of a Self-Stewardship Time-out Program for Renewal of Vancomycin and Piperacillin-Tazobactam.

Graber CJ, Jones MM, Glassman PA, Weir C, Butler J, Nechodom K, Kay CL, Furman AE, Tran TT, Foltz C, Pollack LA, Samore MH, Goetz MB.

Hosp Pharm. 2015 Nov;50(11):1011-24. doi: 10.1310/hpj5011-1011. Epub 2015 Nov 24.

29.

Translation of Contextual Control Model to chronic disease management: A paradigm to guide design of cognitive support systems.

Leecaster MK, Weir CR, Drews FA, Hellewell JL, Bolton D, Jones MM, Nebeker JR.

J Biomed Inform. 2017 Jul;71S:S60-S67. doi: 10.1016/j.jbi.2016.07.003. Epub 2016 Jul 6.

30.

The Effect of a Nationwide Infection Control Program Expansion on Hospital-Onset Gram-Negative Rod Bacteremia in 130 Veterans Health Administration Medical Centers: An Interrupted Time-Series Analysis.

Goto M, O'Shea AMJ, Livorsi DJ, McDanel JS, Jones MM, Richardson KK, Beck BF, Alexander B, Evans ME, Roselle GA, Kralovic SM, Perencevich EN.

Clin Infect Dis. 2016 Sep 1;63(5):642-650. doi: 10.1093/cid/ciw423. Epub 2016 Jun 28.

PMID:
27358355
31.

Does Race Matter in Addressing Homelessness? A Review of the Literature.

Jones MM.

World Med Health Policy. 2016 Jun;8(2):139-156. doi: 10.1002/wmh3.189. Epub 2016 Jun 20.

32.

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.

Harrison CN, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L, Cervantes F, Jones MM, Sun K, McQuitty M, Stalbovskaya V, Gopalakrishna P, Barbui T.

Leukemia. 2016 Aug;30(8):1701-7. doi: 10.1038/leu.2016.148. Epub 2016 May 23. Erratum in: Leukemia. 2017 Mar;31(3):775.

33.

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

Verstovsek S, Vannucchi AM, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Kirito K, Besses C, Hino M, Moiraghi B, Miller CB, Cazzola M, Rosti V, Blau I, Mesa R, Jones MM, Zhen H, Li J, Francillard N, Habr D, Kiladjian JJ.

Haematologica. 2016 Jul;101(7):821-9. doi: 10.3324/haematol.2016.143644. Epub 2016 Apr 21.

34.

Unique Risks and Clinical Outcomes Associated With Extended-Spectrum β-Lactamase Enterobacteriaceae in Veterans With Spinal Cord Injury or Disorder: A Case-Case-Control Study.

Fitzpatrick MA, Suda KJ, Safdar N, Goldstein B, Jones MM, Poggensee L, Ramanathan S, LeWan R, Evans CT.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):768-76. doi: 10.1017/ice.2016.60. Epub 2016 Mar 30.

PMID:
27025908
35.

Exploring provision of Innovative Community Education Placements (ICEPs) for junior doctors in training: a qualitative study.

Griffin A, Jones MM, Khan N, Park S, Rosenthal J, Chrysikou V.

BMJ Open. 2016 Feb 9;6(2):e009931. doi: 10.1136/bmjopen-2015-009931.

36.

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.

Mesa R, Verstovsek S, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Zhen H, Jones MM, Parasuraman S, Li J, Côté I, Habr D, Vannucchi AM.

Eur J Haematol. 2016 Aug;97(2):192-200. doi: 10.1111/ejh.12707. Epub 2016 Jan 3.

PMID:
26608702
37.

Cumulative Attributable Difference: An Infection Metric That Reflects a Value System.

Jones MM, Nelson RE, Rubin MA.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1385-7. doi: 10.1017/ice.2015.231. Epub 2015 Nov 23. No abstract available.

PMID:
26415745
38.

Sampling Methods for Detection and Monitoring of the Asian Citrus Psyllid (Hemiptera: Psyllidae).

Monzo C, Arevalo HA, Jones MM, Vanaclocha P, Croxton SD, Qureshi JA, Stansly PA.

Environ Entomol. 2015 Jun;44(3):780-8. doi: 10.1093/ee/nvv032. Epub 2015 Mar 30.

PMID:
26313984
39.

Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010.

Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M.

Clin Infect Dis. 2015 Nov 1;61(9):1403-10. doi: 10.1093/cid/civ629. Epub 2015 Jul 29.

40.

Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional Study.

Jones BE, Sauer B, Jones MM, Campo J, Damal K, He T, Ying J, Greene T, Goetz MB, Neuhauser MM, Hicks LA, Samore MH.

Ann Intern Med. 2015 Jul 21;163(2):73-80. doi: 10.7326/M14-1933.

41.

Expression of the Oligopeptide Permease Operon of Moraxella catarrhalis Is Regulated by Temperature and Nutrient Availability.

Jones MM, Murphy TF.

Infect Immun. 2015 Sep;83(9):3497-505. doi: 10.1128/IAI.00597-15. Epub 2015 Jun 22.

42.

Expression of IgA Proteases by Haemophilus influenzae in the Respiratory Tract of Adults With Chronic Obstructive Pulmonary Disease.

Murphy TF, Kirkham C, Jones MM, Sethi S, Kong Y, Pettigrew MM.

J Infect Dis. 2015 Dec 1;212(11):1798-805. doi: 10.1093/infdis/jiv299. Epub 2015 May 20.

43.

Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment.

Zou P, Conklin HM, Scoggins MA, Li Y, Li X, Jones MM, Palmer SL, Gajjar A, Ogg RJ.

Brain Imaging Behav. 2016 Mar;10(1):258-71. doi: 10.1007/s11682-015-9390-8.

44.

Creating a science of homelessness during the Reagan era.

Jones MM.

Milbank Q. 2015 Mar;93(1):139-78. doi: 10.1111/1468-0009.12108. Review.

45.

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia.

Arthur C, Cermak J, Delaunay J, Mayer J, Mazur G, Thomas X, Wierzbowska A, Jones MM, Berrak E, Kantarjian H.

J Blood Med. 2015 Jan 8;6:25-9. doi: 10.2147/JBM.S64067. eCollection 2015.

46.

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

Vannucchi AM, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Mesa R, He S, Jones MM, Garrett W, Li J, Pirron U, Habr D, Verstovsek S.

N Engl J Med. 2015 Jan 29;372(5):426-35. doi: 10.1056/NEJMoa1409002.

47.

The Structural Genomics Consortium: A Knowledge Platform for Drug Discovery: A Summary.

Jones MM, Castle-Clarke S, Brooker D, Nason E, Huzair F, Chataway J.

Rand Health Q. 2014 Dec 30;4(3):19. eCollection 2014 Dec 30.

48.

The Future of Public Health: A Horizon Scan.

Jones MM, Hall A, Brooker D, Castle-Clarke S, Winpenny E, Jahagirdar D, Exley J, Chataway J.

Rand Health Q. 2014 Dec 30;4(3):18. eCollection 2014 Dec 30.

49.

Clinical utility of the N-back task in functional neuroimaging studies of working memory.

Jacola LM, Willard VW, Ashford JM, Ogg RJ, Scoggins MA, Jones MM, Wu S, Conklin HM.

J Clin Exp Neuropsychol. 2014;36(8):875-86. doi: 10.1080/13803395.2014.953039. Epub 2014 Sep 25.

50.

Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.

Jones MM, Johnson A, Koszelak-Rosenblum M, Kirkham C, Brauer AL, Malkowski MG, Murphy TF.

Infect Immun. 2014 Nov;82(11):4758-66. doi: 10.1128/IAI.02185-14. Epub 2014 Aug 25.

Supplemental Content

Loading ...
Support Center